An Act relative to patient access to biomarker testing to provide appropriate therapy
By Representative Kilcoyne of Clinton, a petition (accompanied by bill, House, No. 1227) of Meghan K. Kilcoyne and others relative to cancer patient access to biomarker testing to provide appropriate therapy. Financial Services.
Bill History
| Branch | Action | |
|---|---|---|
| 2/27/2025 | House | Referred to the committee on Financial Services |
| 2/27/2025 | Senate | Senate concurred |
| 4/23/2025 | Joint | Hearing scheduled for 04/29/2025 from 10:00 AM-02:00 PM in A-2 |
| 7/31/2025 | House | Accompanied a new draft, see H4339 |
| 8/28/2025 | Joint |
Hearing rescheduled to 04/29/2025 from 10:00 AM-01:00 PM in A-2 and Virtual Hearing updated to New End Time |
The information contained in this website is for general information purposes only. The General Court provides this information as a public service and while we endeavor to keep the data accurate and current to the best of our ability, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.